Sripal Bengaluru

Q: What Schools Are Affiliated With Sripal Bengaluru

Sripal Bengaluru is affiliated with the following schools: New York University, Harvard University, University of California, Berkeley, University at Albany, SUNY, University of Michigan, Stanford University, Columbia University

Sripal Bengaluru's AcademicInfluence.com Rankings

Sripal Bengaluru

Computer Science

#4278

World Rank

#4501

Historical Rank

Computational Linguistics

#380

World Rank

#386

Historical Rank

Machine Learning

#791

World Rank

#802

Historical Rank

Artificial Intelligence

#999

World Rank

#1017

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Sripal Bengaluru's Degrees

PhD Computer Science University of California, Berkeley
Masters Computer Science Stanford University

Similar Degrees You Can Earn

Why Is Sripal Bengaluru Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sripal Bengaluru's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Initial Invasive or Conservative Strategy for Stable Coronary Disease. (2020) (1071)
Fixed-dose combinations improve medication compliance: a meta-analysis. (2007) (1014)
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 (2020) (870)
ST-Segment Elevation in Patients with Covid-19 — A Case Series (2020) (626)
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents: A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials (2012) (562)
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry (2020) (550)
Obesity paradox in patients with hypertension and coronary artery disease. (2007) (507)
Diabetes and Hypertension: A Position Statement by the American Diabetes Association (2017) (465)
Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials (2011) (442)
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial (2018) (413)
Atrial fibrillation and obesity--results of a meta-analysis. (2008) (411)
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. (2012) (376)
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. (2010) (351)
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) (336)
Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis (2008) (335)
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. (2011) (327)
The Transition From Hypertension to Heart Failure: Contemporary Update. (2017) (285)
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis (2013) (280)
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary (2021) (275)
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review. (2019) (275)
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. (2007) (243)
Management of Coronary Disease in Patients with Advanced Kidney Disease. (2020) (239)
Cardiovascular protection using beta-blockers: a critical review of the evidence. (2007) (234)
Everolimus-eluting stents or bypass surgery for multivessel coronary disease. (2015) (228)
What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?: Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial (2010) (223)
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. (2020) (222)
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease (2016) (221)
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials (2012) (217)
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design (2018) (216)
Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery (2017) (216)
Percutaneous Coronary Intervention Versus Optimal Medical Therapy in Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials (2012) (210)
Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. (2014) (206)
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials (2013) (198)
Body‐Weight Fluctuations and Outcomes in Coronary Disease (2017) (181)
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? (2018) (177)
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry. (2016) (169)
Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. (2011) (168)
Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. (2008) (164)
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent (2010) (162)
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials (2018) (159)
Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease: Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (150)
Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. (2012) (148)
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. (2013) (146)
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome. (2011) (142)
Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial. (2015) (141)
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. (2017) (132)
Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents. (2017) (128)
Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. (2012) (128)
Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients. (2017) (126)
Risk/Benefit Assessment of &bgr;-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension (2008) (123)
Machine learning prediction in cardiovascular diseases: a meta-analysis (2020) (121)
Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III) (2014) (120)
Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis (2015) (120)
Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials (2016) (114)
Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. (2015) (110)
Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials (2011) (106)
Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery (2016) (105)
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. (2011) (101)
Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes. (2015) (98)
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial (2019) (95)
Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis. (2016) (95)
Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta‐analysis (2018) (94)
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial (2021) (93)
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. (2009) (92)
Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Prevention of Spontaneous Myocardial Infarction in Subjects With Stable Ischemic Heart Disease (2013) (90)
Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. (2017) (89)
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema. (2011) (89)
Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis. (2008) (88)
Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis. (2020) (88)
Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. (2010) (87)
Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. (2019) (87)
&bgr;-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA Trial (2014) (87)
Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. (2013) (86)
Vascular Closure Device Failure: Frequency and Implications: A Propensity-Matched Analysis (2009) (86)
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of MINOCA in Women. (2020) (85)
Perioperative acute myocardial infarction associated with non-cardiac surgery (2017) (84)
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (84)
Body Weight Changes with β-Blocker Use: Results from GEMINI (2007) (84)
Complete Versus Culprit-Only Revascularization for ST-Segment–Elevation Myocardial Infarction and Multivessel Disease: A Meta-Analysis and Trial Sequential Analysis of Randomized Trials (2015) (83)
The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. (2010) (83)
2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study. (2014) (83)
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. (2014) (81)
Cardiac rehabilitation fitness changes and subsequent survival (2018) (80)
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials. (2016) (79)
Outcomes With Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention for Patients With Diabetes Mellitus: Can Newer Generation Drug-Eluting Stents Bridge the Gap? (2014) (78)
Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease (2020) (77)
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity (2021) (77)
Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-Analysis. (2017) (76)
Percutaneous coronary intervention of moderate to severe calcified coronary lesions: Insights from the National Heart, Lung, and Blood Institute Dynamic Registry (2011) (75)
Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate – a meta-analysis of randomized trials (2011) (73)
Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease. (2011) (71)
Outcomes With Various Drug-Eluting or Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction: A Mixed Treatment Comparison Analysis of Trial Level Data From 34 068 Patient-Years of Follow-up From Randomized Trials (2013) (69)
Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease (2015) (69)
Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. (2007) (69)
Gun ownership and firearm-related deaths. (2013) (68)
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents. (2014) (68)
Concordance with DASH diet and blood pressure change: results from the Framingham Offspring Study (1991–2008) (2015) (68)
Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy (2018) (66)
Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials (2017) (65)
Femoral arterial access and closure. (2011) (64)
Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. (2015) (64)
Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention. (2015) (64)
Impact of COVID‐19 pandemic on STEMI care: An expanded analysis from the United States (2020) (63)
Compliance and fixed-dose combination therapy (2007) (62)
Long‐term cardiovascular mortality after radiotherapy for breast cancer: A systematic review and meta‐analysis (2017) (62)
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. (2008) (60)
Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States (2018) (58)
Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non-ST-Elevation Acute Coronary Syndrome. (2015) (58)
Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials (2012) (58)
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2 (2021) (57)
Assessment of left atrial appendage function with transthoracic tissue Doppler echocardiography. (2009) (57)
No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial (2016) (57)
Role of left atrial size in risk stratification and prognosis of patients undergoing stress echocardiography. (2007) (56)
Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial. (2017) (55)
Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. (2011) (55)
Future Direction for Using Artificial Intelligence to Predict and Manage Hypertension (2018) (53)
Secondary prevention after ischemic stroke or transient ischemic attack. (2014) (52)
Response to letter regarding article, “Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison Analysis of 117,762 patient-years of follow-up from randomized trials”. (2013) (51)
Body weight changes with beta-blocker use: results from GEMINI. (2007) (50)
The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel. (2017) (50)
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. (2020) (49)
Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke. (2013) (47)
Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery (2018) (47)
When an Increase in Central Systolic Pressure Overrides the Benefits of Heart Rate Lowering. (2016) (47)
Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives (2009) (46)
Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors (2014) (45)
Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. (2020) (45)
A meta-analysis and meta-regression of long-term outcomes of transcatheter versus surgical aortic valve replacement for severe aortic stenosis. (2016) (45)
Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke (2017) (45)
Radiation exposure during coronary angiography via transradial or transfemoral approaches when performed by experienced operators. (2013) (45)
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites. (2015) (45)
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches–Chronic Kidney Disease (ISCHEMIA‐CKD): Rationale and design (2018) (45)
Resistant hypertension: what the cardiologist needs to know. (2015) (44)
Risk Factor Variability and Cardiovascular Outcome: JACC Review Topic of the Week. (2019) (44)
Association between Arsenic Exposure from Drinking Water and Longitudinal Change in Blood Pressure among HEALS Cohort Participants (2015) (44)
Vascular closure device failure in contemporary practice. (2012) (44)
Cardiovascular Outcomes of Patients With Pulmonary Hypertension Undergoing Noncardiac Surgery. (2019) (43)
Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. (2015) (43)
Renal denervation for resistant hypertension? (2014) (42)
Short and long-term mortality in women and men undergoing primary angioplasty: A comprehensive meta-analysis. (2015) (42)
Risk stratification using stress echocardiography: incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of bayesian pretest probabilities for coronary artery disease. (2007) (42)
Aspiration thrombectomy in patients undergoing primary angioplasty: Totality of data to 2013 (2014) (41)
Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis. (2009) (40)
Effect of ramipril on the incidence of diabetes. (2007) (40)
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events. (2017) (39)
Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction? (2016) (39)
Wilder's principle: pre-treatment value determines post-treatment response. (2015) (38)
Trend in the use of drug eluting stents in the United States: insight from over 8.1 million coronary interventions. (2014) (38)
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis? (2016) (38)
Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials. (2014) (37)
Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (2018) (37)
Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal DiseaseNovelty and Significance (2014) (37)
Role of right ventricular wall motion abnormalities in risk stratification and prognosis of patients referred for stress echocardiography. (2007) (37)
Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials (2014) (36)
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019 (2020) (35)
Prognostic implications of stress echocardiography and impact on patient outcomes: an effective gatekeeper for coronary angiography and revascularization. (2010) (35)
Telmisartan, ramipril, or both in patients at high risk of vascular events. (2008) (35)
COVID‐19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock (2020) (34)
Complete vs Culprit-Only Percutaneous Coronary Intervention in STEMI With Multivessel Disease: A Meta-analysis and Trial Sequential Analysis of Randomized Trials. (2016) (34)
Cardiac outcomes with submaximal normal stress echocardiography: a meta-analysis. (2012) (34)
Management and outcomes of acute myocardial infarction in patients with chronic kidney disease. (2017) (33)
Late Outcomes After Carotid Artery Stenting Versus Carotid Endarterectomy: Insights From a Propensity-Matched Analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry (2010) (32)
Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis (2017) (32)
Impact of Sex and Contact‐to‐Device Time on Clinical Outcomes in Acute ST‐Segment Elevation Myocardial Infarction—Findings From the National Cardiovascular Data Registry (2017) (32)
Comparison of prognostic value of stress echocardiography versus stress electrocardiography in patients with suspected coronary artery disease. (2005) (31)
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials. (2021) (31)
Angiotensin receptor blockers: baseline therapy in hypertension? (2009) (31)
Sodium intake, life expectancy, and all-cause mortality. (2020) (30)
Cardioprotection with beta‐blockers: myths, facts and Pascal’s wager (2009) (30)
Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. (2013) (29)
Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of Myocardial Infarction. (2017) (29)
The presence, characterization and prognosis of coronary plaques among patients with zero coronary calcium scores (2011) (29)
Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting. (2016) (28)
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States. (2016) (28)
Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials. (2017) (28)
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation. (2021) (28)
Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease. (2016) (27)
Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Cryptogenic Stroke. (2017) (27)
Procedural variation in the performance of primary percutaneous coronary intervention for ST‐elevation myocardial infarction: A SCAI‐based survey study of US interventional cardiologists (2014) (26)
Fifteen‐Year Trends in Management and Outcomes of Non–ST‐Segment–Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000–2014 (2018) (26)
Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions. (2015) (26)
Chemoradiation Therapy versus Chemotherapy Alone for Gastric Cancer after R0 Surgical Resection: A Meta-Analysis of Randomized Trials (2013) (26)
Alport Syndrome Classification and Management (2020) (26)
Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: Results From a Propensity Score–Matched Analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry (2011) (26)
Salt and heart disease: a second round of “bad science”? (2018) (26)
Which, if any, antihypertensive agents cause cancer? (2012) (25)
Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non-Insulin-Treated Diabetes Mellitus: Secondary Analysis of the TUXEDO Trial. (2016) (25)
Changing definition of hypertension in guidelines: how innocent a number game? (2018) (25)
Anomalous right coronary artery and sudden cardiac death. (2012) (25)
Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations (2012) (25)
Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography. (2007) (24)
Stress testing in patients with chronic kidney disease: The need for ancillary markers for effective risk stratification and prognosis (2016) (24)
Meta-analysis of prognostic implications of dyspnea versus chest pain in patients referred for stress testing. (2014) (24)
Treatment resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (23)
Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study. (2011) (23)
Risk of Amputation Associated with Sodium-Glucose Co-Transporter 2 Inhibitors: A Meta-Analysis of Five Randomized Controlled Trials. (2020) (23)
Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial. (2021) (23)
A randomized comparison of modified subcutaneous “Z”‐stitch versus manual compression to achieve hemostasis after large caliber femoral venous sheath removal (2018) (23)
Of statistical significance: "trends" toward significance and optimism bias. (2006) (23)
Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin. (2006) (22)
Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks. (2015) (22)
Management of hypertension in 2017: targets and therapies (2017) (22)
Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta‐analysis of observational studies (2016) (22)
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome (2021) (22)
Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. (2011) (21)
PML in Patients Treated with Dimethyl Fumarate. (2015) (21)
Antihypertensive efficacy of angiotensin receptor blockers as monotherapy as evaluated by ambulatory blood pressure monitoring: a meta-analysis. (2014) (21)
When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist? (2013) (21)
Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark? (2009) (21)
Treatment-resistant hypertension: another Cinderella story. (2013) (21)
Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial. (2021) (21)
Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease. (2017) (21)
Usefulness of stress echocardiography for risk stratification and prognosis of patients with left ventricular hypertrophy. (2007) (20)
Misconceptions and Facts About Beta-Blockers. (2019) (20)
A routine invasive strategy for out-of-hospital cardiac arrest survivors: are we there yet? (2010) (20)
Coronary intravascular ultrasound. (2013) (19)
Images in cardiovascular medicine. Right heart catheterization, coronary angiography, and percutaneous coronary intervention. (2011) (19)
Age, Blood Pressure Targets, and Guidelines: Rift Between Those Who Preach, Those Who Teach, and Those Who Treat? (2018) (19)
Risk Stratification and Prognosis in Octogenarians Undergoing Stress Echocardiographic Study (2007) (19)
Predictors of Access Site Crossover in Patients Who Underwent Transradial Coronary Angiography. (2015) (19)
Inotropic contractile reserve and response to cardiac resynchronization therapy in patients with markedly remodeled left ventricle. (2011) (19)
Temporal trends in clinical characteristics of patients without known cardiovascular disease with a first episode of myocardial infarction. (2014) (19)
Evidence-Based Management of Stable Ischemic Heart Disease: Challenges and Confusion. (2015) (19)
Comparison of heart rate reserve versus 85% of age-predicted maximum heart rate as a measure of chronotropic response in patients undergoing dobutamine stress echocardiography. (2006) (19)
The association between coronary graft patency and clinical status in patients with coronary artery disease. (2021) (18)
Drug-Eluting vs Bare-Metal Stents in Patients With Chronic Kidney Disease and Coronary Artery Disease: Insights From a Systematic Review and Meta-Analysis. (2018) (18)
A novel pathway for the management of hypertension for hospitalized patients. (2007) (18)
Outcomes with bioabsorbable vascular scaffolds versus everolimus eluting stents: Insights from randomized trials. (2016) (18)
Incremental Prognostic Value of Stress Echocardiography Over Clinical and Stress Electrocardiographic Variables in Patients With Prior Myocardial Infarction: “Warranty Time” of a Normal Stress Echocardiogram (2006) (18)
The Blood Pressure Landscape: Schism Among Guidelines, Confusion Among Physicians, and Anxiety Among Patients. (2018) (18)
Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert. (2013) (17)
Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association (2021) (17)
Influence of Human Immunodeficiency Virus Seropositive Status on the In-Hospital Management and Outcomes of Patients Presenting With Acute Myocardial Infarction. (2016) (17)
The Effect of Statin Therapy on Ventricular Tachyarrhythmias: A Meta-Analysis (2012) (17)
ALTITUDE trial and dual RAS blockade: the alluring but soft science of the surrogate end point. (2013) (16)
Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial. (2018) (16)
β‐blockers as fourth‐line therapy for hypertension: stay the course (2008) (16)
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. (2017) (16)
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI. (2021) (16)
Letter by Messerli and Bangalore Regarding Article, "Association of Blood Pressure Measurements With Peripheral Artery Disease Events". (2019) (16)
Association of major dietary patterns and blood pressure longitudinal change in Bangladesh (2015) (16)
In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States (2018) (16)
Comparison of Outcomes of Patients With Sepsis With Versus Without Acute Myocardial Infarction and Comparison of Invasive Versus Noninvasive Management of the Patients With Infarction. (2016) (16)
Ezetimibe plus moderate-dose simvastatin after acute coronary syndrome: what are we IMPROVEing on? (2015) (15)
Fixed-Dose Combinations Improve Medication (2007) (15)
Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease. (2012) (15)
A prospective study of arm circumference and risk of death in Bangladesh. (2014) (15)
PCSK9 Inhibitors for Statin Intolerance? (2016) (15)
Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease (2015) (15)
Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta‐analysis (2020) (15)
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk (2020) (15)
Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: a meta-analysis. (2013) (15)
The Prognostic Impact of High On-Treatment Platelet Reactivity with Aspirin or ADP Receptor Antagonists: Systematic Review and Meta-Analysis (2014) (15)
Heparin Monotherapy or Bivalirudin During Percutaneous Coronary Intervention in Patients With Non–ST-Segment–Elevation Acute Coronary Syndromes or Stable Ischemic Heart Disease: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events Registry (2014) (14)
Meta-Analysis of Randomized Trials on the Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients ≥65 Years of Age. (2016) (14)
"One" cup of coffee and nuclear SPECT to go. (2007) (14)
Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials. (2020) (14)
The Burden of Atherosclerotic Cardiovascular Disease in South Asians Residing in Canada: A Reflection From the South Asian Heart Alliance (2019) (14)
Abstract 16116: Drug Eluting vs. Bare Metal Stents in Patients With Chronic Kidney Disease and Coronary Artery Disease: Insight From a Systematic Review and Meta-Analysis of Trials (2013) (14)
Identification of gene expression profiles in myocardial infarction: a systematic review and meta-analysis (2018) (13)
Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non–ST-Segment–Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States (2017) (13)
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease. (2020) (13)
Meta-Analysis Comparing WatchmanTM and Amplatzer Devices for Stroke Prevention in Atrial Fibrillation (2020) (13)
Should We SPRINT Toward New Blood Pressure Goals or Let the Dust Settle? (2016) (13)
Hypertension control and cardiovascular disease (2017) (13)
Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials (2019) (13)
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT. (2017) (13)
Body-Weight Fluctuations and Outcomes in Coronary Disease. (2017) (13)
The Potential Effects of New Stent Platforms for Coronary Revascularization in Patients With Diabetes. (2018) (12)
Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. (2019) (12)
Long‐term efficacy and safety of zotarolimus‐eluting stent in patients with diabetes mellitus: Pooled 5‐year results from the ENDEAVOR III and IV trials (2013) (12)
Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure. (2012) (12)
Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery (2017) (12)
Triple versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Adding Cilostazol to Aspirin and Clopidogrel? (2013) (12)
Effectiveness of fluorography versus cineangiography at reducing radiation exposure during diagnostic coronary angiography. (2014) (12)
A Case of Cardiogenic Shock Secondary to Complement-Mediated Myopericarditis From Influenza B Infection. (2017) (12)
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies (2020) (11)
Outcomes With Complete Versus Incomplete Revascularization in Patients With Multivessel Coronary Disease Undergoing Percutaneous Coronary Intervention With Everolimus Eluting Stents. (2019) (11)
From Door‐to‐Balloon Time to Contact‐to‐Device Time: Predictors of Achieving Target Times in Patients With ST‐Elevation Myocardial Infarction (2014) (11)
ISCHEMIA: Establishing the Primary End Point. (2018) (11)
Risk Stratification and Prognosis of Human Immunodeficiency Virus–Infected Patients With Known or Suspected Coronary Artery Disease Referred for Stress Echocardiography (2011) (11)
Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial. (2014) (11)
Design and Rationale of the XIENCE Short DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-month DAPT in Patients at High Bleeding Risk Undergoing PCI with an Everolimus-Eluting Stent. (2020) (11)
Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association (2021) (11)
The Elusive Late Benefit of Biodegradable Polymer Drug-Eluting Stents (2019) (11)
Cardiovascular hazards of insufficient treatment of depression among patients with known cardiovascular disease: a propensity score adjusted analysis (2018) (11)
Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization. (2017) (10)
Embolic protection devices. (2014) (10)
Percutaneous Coronary Intervention Versus Optimal Medical Therapy in Stable Coronary Artery Disease (10)
Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention. (2010) (10)
Coronary Intervention in Patients With Acute Coronary Syndrome: Does Every Culprit Lesion Require Revascularization? (2010) (10)
Beta-blockers after acute myocardial infarction: an old drug in urgent need of new evidence! (2020) (10)
Do We Need a Trial of DES Versus CABG Surgery in Diabetic Patients With ACS? (2017) (10)
Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend. (2020) (10)
Safety and efficacy of mechanical circulatory support with Impella or intra‐aortic balloon pump for high‐risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta‐analysis of randomized trials (2020) (10)
Perioperative cardiovascular outcomes of non-cardiac solid organ transplant surgery (2018) (10)
Stress function index, a novel index for risk stratification and prognosis using stress echocardiography. (2005) (9)
Antihypertensive Therapy and the J-curve: Fact or Fiction? (2015) (9)
Cardiogenic shock complicating multisystem inflammatory syndrome following COVID-19 infection: a case report (2021) (9)
Prognostic value of myocardial ischemic electrocardiographic response in patients with normal stress echocardiographic study. (2014) (9)
Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study. (2020) (9)
Blood Pressure Variability and Arterial Stiffness-Chicken or Egg? (2019) (9)
P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials. (2020) (9)
Beta-blockers and exercise. (2006) (9)
Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review (2017) (9)
A prospective study of variability in systolic blood pressure and mortality in a rural Bangladeshi population cohort. (2013) (9)
Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation (2016) (9)
Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Associati (2009) (9)
Resting heart rate and cardiovascular disease: the beta-blocker-hypertension paradox. (2008) (9)
Cholesterol variability: a marker for increased risk or a risk factor? (2017) (8)
Lowering the Thresholds of Diseases: Is Anyone Still Healthy? (2018) (8)
Outcomes of Participants With Diabetes in the ISCHEMIA Trials (2021) (8)
Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney disease. (2020) (8)
Optimal aspirin dose in acute coronary syndromes: an emerging consensus. (2014) (8)
Diuretic-based regimens for obese patients? (2013) (8)
Ivabradine in Cardiovascular Disease Management Revisited: a Review (2021) (8)
Letter by Messerli et al Regarding Article, "The Implications of Blood Pressure Measurement Methods on Treatment Targets for Blood Pressure". (2017) (8)
Effect of arteriovenous fistula creation on systolic and diastolic blood pressure in patients with pre-dialysis advanced chronic kidney disease. (2019) (8)
Title Everolimus-eluting stents or bypass surgery for multivesselcoronary disease (2015) (8)
Paclitaxel-eluting stents versus everolimus-eluting coronary stents in a diabetic population: two-year follow-up of the TUXEDO-India trial. (2017) (8)
First-Generation Bioresorbable Vascular Scaffolds: Disappearing Stents or Disappearing Evidence? (2017) (8)
Applicability of the COURAGE, BARI 2D, and FREEDOM Trials to Contemporary Practice. (2016) (8)
Stable coronary artery disease: are there therapeutic benefits of heart rate lowering? (2019) (8)
Is there an ischemic threshold beyond which percutaneous coronary intervention is beneficial in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial? (2007) (8)
Drug‐eluting stents versus bare metal stents prior to noncardiac surgery (2015) (8)
When guidelines need guidance... (2008) (7)
Potent P2Y12 Inhibitors versus Clopidogrel in Elderly Patients with Acute Coronary Syndrome: Systematic Review and Meta-Analysis: P2Y12 inhibitors and elderly patients with ACS. (2021) (7)
Survival After Invasive or Conservative Management of Stable Coronary Disease (2022) (7)
The muddy waters of the J-curve and coronary revascularization. (2020) (7)
Prediction of myocardial infarction versus cardiac death by stress echocardiography. (2009) (7)
Do angiotensin receptor blockers prevent myocardial infarctions as well as other initial therapies? (2012) (7)
Diagnostic, Therapeutic, and Clinical Trial Conundrum of Patients With Chronic Kidney Disease. (2016) (7)
Prognostic value of fractional flow reserve using computed tomography for predicting major adverse cardiac events and mortality in kidney transplant candidates (2021) (7)
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. (2021) (7)
A review of stroke in patients with hypertension and coronary artery disease: focus on calcium channel blockers (2006) (7)
Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization (2021) (7)
Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database (2015) (6)
Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta‐Analysis (2021) (6)
P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials (2022) (6)
Cardiovascular Risk Factors: It's Time to Focus on Variability! (2020) (6)
Introduction: Controversies in Hypertension. (2016) (6)
Effects of Bardoxolone Methyl in Alport Syndrome (2021) (6)
Efficacy and safety of the nitinol clip-based vascular closure device (Starclose) for closure of common femoral arterial cannulation at or near the bifurcation: a propensity score-adjusted analysis. (2011) (6)
Perioperative bleeding and thrombotic risks in patients with Von Willebrand disease (2017) (6)
Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial. (2022) (6)
Cardioversion in patients with left ventricular thrombus is not associated with increased thromboembolic risk. (2006) (6)
Stress echocardiography: risk stratification, prognosis, patient outcomes and cost-effectiveness. (2009) (6)
The Pickering Syndrome – A pebble in the mosaic of the cardiorenal syndrome (2011) (6)
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial. (2022) (6)
Perindopril vs Enalapril in Patients with Systolic Heart Failure: Systematic Review and Metaanalysis. (2014) (6)
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction A (2016) (6)
Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis: an Updated Review of Literature (2014) (6)
Detection of Atherosclerotic Cardiovascular Disease in Patients with Advanced Chronic Kidney Disease in the Cardiology and Nephrology Communities (2018) (6)
Cross-sectional imaging identifies flow-mediated vasodilatation more accurately compared with longitudinal imaging. (2007) (6)
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial. (2022) (5)
Efficacy and Safety of Selective Vascular Endothelial Growth Factor Receptor Inhibitors Compared with Sorafenib for Metastatic Renal Cell Carcinoma: a Meta-analysis of Randomised Controlled Trials. (2016) (5)
Obesity and mortality: a poorly understood relationship. (2007) (5)
Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds? (2009) (5)
Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial. (2021) (5)
Comparison of SYNTAX score strata effects of percutaneous and surgical revascularization trials: A meta-analysis. (2021) (5)
Statin therapy for secondary prevention: is there a gender difference? Test for interaction in meta-analysis revisited. (2012) (5)
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA (2022) (5)
β-blockers: No longer an option for uncomplicated hypertension (2007) (5)
Blood pressure control and mortality in US‐ and foreign‐born blacks in New York City (2017) (5)
Role of angiographic coronary artery collaterals in transient ischemic left ventricular cavity dilatation during stress echocardiography (2006) (5)
Hypertension in the elderly: a compelling contraindication for beta-blockers? (2007) (5)
Hypertension in the elderly: a compelling contraindication for β-blockers? (2007) (5)
Biodegradable Polymers and Stents: the Next Generation? (2019) (5)
Good news from Lake Wobegon. (2006) (5)
Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-Analysis (2018) (5)
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome: Insights from a network meta-analysis of randomized trials. (2020) (5)
Retrograde approach to an ostial left anterior descending chronic total occlusion through a left internal mammary artery graft (2016) (5)
Saddle pulmonary embolism and clot in transit in COVID-19 infection: a case report of catastrophic venous thromboembolism (2020) (5)
Blood pressure and stroke: findings from recent trials. (2011) (4)
Economic burden associated with inadequate antidepressant medication management among patients with depression and known cardiovascular diseases: insights from a United States–based retrospective claims database analysis (2020) (4)
How and When to Decide on Revascularization in Stable Ischemic Heart Disease (2013) (4)
Patterns of Use and Clinical Outcomes with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Heart Failure and Changes in Kidney Function: An Analysis of the Veterans’ Health Administrative Database (2021) (4)
Comparison of stress-induced myocardial ischemia in patients with and without coronary arterial collaterals. (2004) (4)
Challenges with Evidence-Based Management of Stable Ischemic Heart Disease (2017) (4)
β-Blockers: No longer an option for uncomplicated hypertension (2008) (4)
ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials. (2016) (4)
Predictors of Outcome in the ISCHEMIA-CKD Trial: Anatomy versus Ischemia. (2021) (4)
Statins for Prevention of Contrast-Associated Acute Kidney Injury: Is the Debate a Moot Point? (2019) (4)
THIN VERSUS THICK STRUT STENT FOR PERCUTANEOUS CORONARY INTERVENTION USING BARE METAL STENTS: INSIGHTS FROM THE NHLBI PCI DYNAMIC REGISTRY (2010) (4)
Cardiovascular disease care fragmentation in kidney transplantation: a call for action. (2019) (4)
Prasugrel in the Elderly (2018) (4)
Abstract 4602: Complete Revascularization in Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Meta Analysis (2009) (4)
Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association. (2022) (4)
Perioperative β blockade (2008) (4)
Comparison of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention in Patients with Diabetes (2015) (4)
Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease (2020) (4)
Salt, Tomato Soup, and the Hypocrisy of the American Heart Association. (2017) (4)
Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials. (2018) (4)
Acute coronary syndromes in the peri‐operative period after kidney transplantation in United States (2020) (4)
Mortality in patients undergoing revascularization with paclitaxel eluting devices for infrainguinal peripheral artery disease: Insights from a network meta‐analysis of randomized trials (2020) (4)
Response to letter regarding article, "Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?". (2014) (4)
Systematic Review/Meta-analysis Complete vs Culprit-Only Percutaneous Coronary Intervention in STEMI With Multivessel Disease: A Meta-analysis and Trial Sequential Analysis of Randomized Trials (2016) (4)
Procedural Volume and Outcomes After Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction in Kerala, India: Report of the Cardiological Society of India–Kerala Primary Percutaneous Coronary Intervention Registry (2020) (4)
SUBSTANTIAL VARIABILITY BETWEEN LABORATORIES IN TROPONIN DECISION LEVEL FOR DIAGNOSIS OF MYOCARDIAL INFARCTION AND ASSAY 99TH PERCENTILE: FINDINGS FROM THE INTERNATIONAL STUDY OF COMPARATIVE HEALTH EFFECTIVENESS WITH MEDICAL AND INVASIVE APPROACHES (ISCHEMIA) TRIAL (2014) (3)
Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial. (2022) (3)
Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: Toward Patient-Centric Decision Making. (2019) (3)
The Glass Is at Least Half Full. (2021) (3)
Tricuspid valve vegetation debulking using the AngioVac system (2021) (3)
PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials. (2017) (3)
Are ACE inhibitors acceptable ingredients in polypills? (2017) (3)
Adverse effects and tolerability of β blockers (2016) (3)
Everolimus eluting stents in patients with diabetes mellitus and chronic kidney disease: Insights from the TUXEDO trial. (2019) (3)
How useful are beta-blockers in cardiovascular disease? (2006) (3)
Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)". (2015) (3)
Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD (2022) (3)
ISCHEMIA-EXTEND Studies: Rationale and Design. (2022) (3)
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial (2022) (3)
Invasive Management of Coronary Artery Disease in Advanced Renal Disease (2021) (3)
Heart Rate in Coronary Artery Disease: Should We Lower It? (2013) (3)
The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence. (2017) (3)
Dobutamine stress echocardiography: Does it predict response to beta-blockers in patients with heart failure? (2006) (3)
What Ever Happened to Cardioprotection With β-Blockers? (2018) (3)
Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey. (2020) (3)
Community acute kidney injury is associated with short- and long-term adverse outcomes in patients admitted with acute myocardial infarction . (2018) (3)
Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST‐Segment–Elevation Myocardial Infarction (2022) (2)
Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply. (2020) (2)
Choosing the Right Coronary Stent in the Modern Era (2014) (2)
Abstract 4418: Carotid Endarterectomy versus Carotid Artery Stenting: Insights From a Propensity Matched Analysis of the REduction of Atherothrombosis for Continued Health (REACH) Registry (2009) (2)
Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer. (2020) (2)
Is the Use of Bare-Metal Stents Justifiable in the Era of Second-Generation Drug-Eluting Stents? (2016) (2)
Coronary morphological features in women with non-ST-segment elevation MINOCA and MI-CAD as assessed by optical coherence tomography (2022) (2)
Ivabradine in Coronary Heart Disease-The Emperor Has No Clothes. (2017) (2)
Translation of critical pathways for acute coronary syndrome and for acute heart failure into admission forms and discharge planning. (2005) (2)
Is dual renin-angiotensin-system blockade associated with increased risk of stroke? (2013) (2)
Effect of Cooling Methods and Target Temperature on Outcomes in Comatose Patients Resuscitated from Cardiac Arrest: Systematic Review and Network Meta-Analysis of Randomized Trials. (2022) (2)
STEMI outcomes in the era of COVID-19: reaffirmation of an unfortunate reality. (2021) (2)
Protected Rotational Atherectomy and DK NanoCrush POT rePOT Technique With Dual Guiding Catheters for Unprotected Distal Left Main. (2020) (2)
Renin–angiotensin system inhibitors and risk of cancer (2011) (2)
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus‐eluting stents (2020) (2)
NEW ORAL ANTICOAGULANTS AND GASTROINTESTINAL BLEEDING: INSIGHTS FROM META-ANALYSES AND TRIAL SEQUENTIAL ANALYSES OF RANDOMIZED CLINICAL TRIALS (2014) (2)
Valsartan inefficacy or ill-effects of concomitant medications! (2010) (2)
STAINLESS STEEL VERSUS NON-STAINLESS STEEL STENTS FOR PERCUTANEOUS CORONARY INTERVENTION USING BARE METAL STENTS: FINDINGS FROM THE NHLBI PCI DYNAMIC REGISTRY (2010) (2)
The "Fragility" of Mortality Benefit of Coronary Artery Bypass Graft Surgery in Diabetics. (2019) (2)
Lipid‐Lowering in African Americans in ALLHAT—Optimism Bias? (2013) (2)
RELATIONSHIP OF HEART RATE AND CARDIOVASCULAR EVENTS IN PATIENTS AFTER ACUTE CORONARY SYNDROMES: AN ANALYSIS FROM THE PROVE-IT TIMI 22 TRIAL (2010) (2)
Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial. (2022) (2)
Diagnostic and Therapeutic Cardiovascular Procedures Femoral Arterial Access and Closure (2011) (2)
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies (2021) (2)
Abstract 2893: Defining the "Blanking Period" after ablation of Atrial Fibrillation: Systematic Study Using a Continuous Autotrigger Recorder for 3 Months (2006) (2)
COVID-19-induced latent relapsing hypercoagulable state in the absence of persistent viral infection (2022) (2)
Trends in the Incidence and In‐Hospital Outcomes of Cardiogenic Shock Complicating Thyroid Storm☆ (2017) (2)
CORONARY ANATOMY, ISCHEMIA AND ANGINA: ASSOCIATIONS AT BASELINE IN THE ISCHEMIA TRIAL (2020) (2)
Risk Factor Variability and Cardiovascular Outcome (2019) (2)
Prognostic value of computed tomography derived fractional flow reserve for predicting cardiac events and mortality in kidney transplant candidates. (2022) (2)
Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors? (2022) (2)
Preventive Strategies for Contrast-Induced Acute Kidney Injury: And the Winner Is…. (2017) (2)
TCT-176 Implantation of Thin-Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With De Novo Coronary Artery Lesions: 2-Year Clinical and 6-Month Imaging Outcomes of the MeRes-1 Extend Trial (2019) (2)
J-Curve Phenomenon: Does It Exist? (2012) (2)
Translation of the RACE pathway for management of atrial fibrillation and atrial flutter into admission forms. (2006) (2)
TCT-14 Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non–ST-Elevation Myocardial Infarction (2021) (2)
Abstract 13061: Trends in Incidence, Management and Outcomes of Heart Failure Patients with Cardiogenic Shock (2014) (2)
Does VALIDATE-SWEDEHEART invalidate the use of bivalirudin in myocardial infarction? (2018) (2)
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial (2022) (2)
Heart rate lowering by beta-blockade and cardiovascular events. (2016) (2)
FLASH PULMONARY EDEMA (FPE) AND BILATERAL RENAL ARTERY STENOSIS (RAS) - THE PICKERING SYNDROME - A HYPERTENSIVE EMERGENCY: HT.3.06 (2010) (2)
Residual stroke risk after left atrial appendage closure in patients with prior Oral anticoagulation failure. (2022) (2)
Beta-Blocker Therapy After Myocardial Infarction: Is There an Expiry Date? (2020) (2)
Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune‐Mediated Inflammatory Diseases: A Systematic Review and Meta‐Analysis of Randomized Trials (2022) (2)
Optimal renin–angiotensin system blockade—wishful thinking? (2013) (2)
Complete revascularization in contemporary practice. (2013) (2)
DOES TRIPLE THERAPY WITH CILOSTAZOL REDUCE THE RISK OF RESTENOSIS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? INSIGHTS FROM A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (2012) (1)
A Clinical Perspective on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease (2022) (1)
Predictors of Access Site Crossover in Patients Undergoing Transradial Coronary Angiography (2015) (1)
Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD (2022) (1)
[OP.LB01.02] OPTIMAL SYSTOLIC BLOOD PRESSURE TARGET AFTER SPRINT INSIGHTS FROM A NETWORK META-ANALYSIS OF RANDOMIZED TRIALS (2016) (1)
How useful are β-blockers in cardiovascular disease? Kardiyovasküler hastal›klarda β-blokerler ne kadar yararl›? (2006) (1)
Reply: Adequate Blood Pressure Control and Monitoring Acute Kidney Injury in Older Hypertensive Patients. (2017) (1)
A Call to Consider an Aortic Stenosis Screening Program. (2023) (1)
Fraudulent data: an apology and the fate of angiotensin receptor blockers (2013) (1)
TCT-845 Percutaneous Coronary Intervention is Associated with Lower Mortality Compared with Optimal Medical Therapy in Patients with Stable Ischemic Heart Disease and Objective Evidence of Ischemia or Abnormal Fractional Flow Reserve: A Meta-Analysis of Randomized Controlled Trials (2013) (1)
Revascularization and survival in multivessel coronary artery disease in ischemia (2022) (1)
Acute Thrombogenicity of SYNERGY Drug-Eluting Stent: The "Bare Metal" Concern? (2019) (1)
PROCEDURAL VARIATION IN THE PERFORMANCE OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-ELEVATION MYOCARDIAL INFARCTION: A SURVEY STUDY OF US INTERVENTIONAL CARDIOLOGISTS (2012) (1)
Choosing between percutaneous coronary intervention and coronary artery bypass graft surgery for nondiabetic patients with multivessel disease. (2016) (1)
Dietary salt reduction; further lowering of target lowers blood pressure but may increase risk (2013) (1)
Abstract 13030: Causes of Cardiovascular and Non-cardiovascular Mortality in the Ischemia Trial (2020) (1)
Crush techniques for percutaneous coronary intervention of bifurcation lesions. (2021) (1)
Abstract 18272: The Increasing Proportion of Acute Myocardial Infarction Represented by the Uninsured: a Growing Financial Burden in the United States (2014) (1)
Provisional or 2-Stent Technique for Bifurcation Lesions in the Second-Generation Drug-Eluting Stent Era (2022) (1)
TCT-539 Clinical outcomes in high bleeding risk patients undergoing complex PCI with the Xience everolimus eluting stent: a patient-level pooled analysis from four Xience post-approval trials (2018) (1)
Blood pressure lowering in patients with type 2 diabetes improves cardiovascular events including mortality, but more intensive lowering to systolic blood pressure less than 130 mm Hg is associated with further reduction in stroke and albuminuria without further reduction in cardiac events (2015) (1)
Eighth joint national committee: evidence versus eminence. (2014) (1)
Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time? (2019) (1)
Abstract 2018: Inotropic Contractile Reserve is a Strong Predictor of Response to Cardiac Resynchronization Therapy (2006) (1)
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial. (2023) (1)
PREDICTION OF LEFT MAIN DISEASE USING CLINICAL AND STRESS TEST PARAMETERS (2020) (1)
TCT-329 Effectiveness of Fluoroscopy-Save versus Cinematography at Reducing Radiation Exposure During Diagnostic Coronary Angiography: A Randomized Controlled Trial (2012) (1)
Systematic reviews and meta-analyses in cardiac surgery: rules of the road - 2. (2020) (1)
Abstract 4372: Tandem Heart(R) Percutaneous Ventricular Assist Device for Treatment of Cardiogenic Shock in Ischemic Versus Nonischemic Cardiomyopathy: A Single-Center Experience (2009) (1)
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension? (2006) (1)
TCT-457 Paclitaxel - eluting stents vs Everolimus - eluting Coronary Stents in a Diabetic population: 2 Years Follow-up of TUXEDO-India Trial. (2016) (1)
Response by Bangalore to Letter Regarding Article, "Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials". (2019) (1)
In hypertensive patients with elevated risk of cardiovascular disease, targeting systolic blood pressure to less than 120 mm Hg significantly reduces the rate of fatal and non-fatal cardiovascular events as well as death from any cause (2016) (1)
Renal Denervation in Hypertension: Barking Up the Wrong Tree? (2021) (1)
Imaging and 2‐year clinical outcomes of thin strut sirolimus‐eluting bioresorbable vascular scaffold: The MeRes‐1 extend trial (2020) (1)
Left Ventricular Hypertrophy Regression after Percutaneous Aortic Valve Replacement : A Sign of More Good Things to Come? (2009) (1)
Siesta, all-cause mortality, and cardiovascular mortality: is there a "siesta" at adjudicating cardiovascular mortality? (2007) (1)
Body weight variability and cardiovascular outcomes in patients with type 2 diabetes (2018) (1)
Salt consumption at a population level remains remarkably steady over time. (2021) (1)
Assumptions and extrapolation (2009) (1)
Abbreviations: CAS, carotid artery stenting; CEA, carotid endarterectomy; CI, confidence interval; MI, myocardial infarction; OR, odds ratio. (2017) (1)
Corrigendum to "Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials" [Int. J. Cardiol. (2017) 137-144]. (2017) (1)
OUTCOMES WITH DRUG ELUTING OR BARE METAL STENTS IN SUBJECTS WITH DIABETES MELLITUS: A MIXED TREATMENT COMPARISON ANALYSIS OF 19,325 PATIENT-YEARS OF FOLLOW-UP FROM RANDOMIZED TRIALS (2012) (1)
Dual RAS blockade—unresolved controversy? (2013) (1)
Drug-eluting versus bare-metal coronary stents: where are we now? (2012) (1)
Authors’ reply to Laragh and Sealey (2013) (1)
Abstract 4231: Impact of Stress Echocardiography on Patient Outcome: An Effective Gatekeeper for Coronary Angiography (2008) (1)
Lung Sestamibi Uptake on Myocardial Perfusion Imaging and Outcomes in Chronic Kidney Disease (2021) (1)
Cardiovascular risk stratification after renal transplant: Is SPECT-MPI the answer? (2017) (1)
DOES TRIPLE THERAPY WITH CILOSTAZOL DECREASE PLATELET REACTIVITY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? A META ANALYSIS OF RANDOMIZED CLINICAL TRIALS (2012) (1)
Reply: aspiration thrombectomy: an easily forgiven "latecomer". (2014) (1)
Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack. (2019) (1)
Abstract 17007: Racial Trends in Angiographic Evaluation and Revascularization for Non-ST Segment Myocardial Infarction: The Atherosclerosis Risk in Communities Surveillance Study (2017) (1)
Abstract 11118: Temporal Trends in Clinical Characteristics of Patients Without Known Coronary Artery Disease Presenting With a First Episode of Myocardial Infarction (2013) (1)
BIVALIRUDIN VERSUS HEPARIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM META-ANALYSIS OF RANDOMIZED TRIALS (2018) (1)
Systematic reviews and meta-analyses in cardiac surgery: rules of the road - 1. (2020) (1)
Perioperative β blockade: the debate continues – Authors' reply (2009) (1)
β-Blocker use for patients with or at risk for coronary artery disease--reply. (2013) (1)
In-hospital Outcomes of Patients With and Without Previous Coronary Artery Bypass Graft Surgery Who Present With a Non-ST-Segment Elevation Myocardial Infarction. (2023) (1)
JAMA Peer Reviewers in 2018. (2019) (1)
1001-31 Incremental prognostic value of stress echocardiography over historical, clinical, and stress electrocardiographic variables across a wide spectrum of Bayesian pretest probability for coronary artery disease (2004) (1)
TCT-683 A Meta-analysis and Meta-regression of Long-Term Outcomes of Transcatheter versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis. (2016) (1)
FDA drug information that never reaches clinicians. (2010) (1)
Abstract 603: Stress Echocardiography is an Effective Gatekeeper for Coronary Revascularization (2009) (1)
Toward a more responsible news media. (2013) (1)
Timing of Statin Dose: A Systematic Review and Meta-analysis of Randomized Clinical Trials. (2022) (1)
Prevalence and Predictors of Cardiogenic Shock in Intermediate-Risk Pulmonary Embolism: Insights From the FLASH Registry. (2023) (1)
Abstract 12079: Initial Report From an Emergency-Department-Based Registry of NSTEMI Patients Given Upstream Advanced Oral Antiplatelet Therapy (2016) (1)
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial. (2023) (1)
Renal denervation: will the Phoenix rise from the ashes? (2017) (1)
In Reply-The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality. (2016) (1)
Simple‐Minded Antihypertensive Treatment: Of Assumptions, Potpourri, and Sausages (2009) (1)
Choosing between aspirin or P2Y12 monotherapy after short course of DAPT. (2020) (1)
Timing of Invasive Coronary Angiography in NSTEMI. (2023) (0)
Faculty Opinions recommendation of Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. (2012) (0)
Screening for participants in the ISCHEMIA trial: Implications for clinical research (2022) (0)
Abstract 10329: Health Status Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grating in Stable Coronary Disease: Secondary Analysis of the ISCHEMIA Trial (2021) (0)
Abstract 3761: Diabetic Patients with Abnormal Stress Echocardiography have worse Prognosis Compared to Patients with Known Coronary Artery Disease: A Stress Echocardiography Study (2007) (0)
Abstract 13000: Trends in Incidence, Invasive Management and Outcomes of Cardiogenic Shock Complicating Non ST-Segment Elevation Myocardial Infarction (2014) (0)
Diagnosis and Treatment of Cardiogenic Shock (2008) (0)
Cerebrovascular Events Complicating Cardiac Catheterization - A Tertiary Care Cardiac Centre Experience (2021) (0)
Pathway for the Management of Patients Based on Stress Echo Results (2009) (0)
Reporting data from meta-analysis: snapshot of a moving target. (2021) (0)
Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial. (2008) (0)
Multivessel Coronary Artery Disease (2018) (0)
Abstract 11266: Prognostic Implications of Normal Stress Echocardiogram in Patients With Angiographically Significant Coronary Artery Disease (2010) (0)
Chronic Kidney Disease and Coronary Artery Disease (0)
Abstract 17: Association Between Age And Health Status In Chronic Coronary Disease With An Initial Invasive Or Conservative Strategy: Insights From The ISCHEMIA Trial (2022) (0)
Reply: What Is the Ideal Blood Pressure Goal for Heart Failure Patients? (2018) (0)
Outcomes After Tricuspid Valve Operations in Patients With Drug-Use Infective Endocarditis. (2022) (0)
Aspirin use is not associated with primary prevention of all-cause, cardiovascular, or oncologic mortality.(Report) (2014) (0)
Global Outcomes ( KDIGO ) Controversies Chronic kidney disease and valvular heart disease : conclusions from a Kidney Disease : Improving Conference (2019) (0)
Optimal Hemostatic Band Duration After Transradial Angiography or Intervention: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials (2023) (0)
PROGNOSTIC VALUE OF ELEVATED LUNG SESTAMIBI UPTAKE IN END-STAGE RENAL DISEASE PATIENTS (2020) (0)
TCT-304 Long term clinical outcomes in acute coronary syndrome patients at high bleeding risk undergoing PCI with implantation of everolimus-eluting stents: Results from the Patient-Level Pooled Analysis of EES Post Approval Studies. (2018) (0)
Major infections after bypass surgery and stenting: an overlooked but fatal complication. (2020) (0)
Abstract 1859: Stress Echocardiography can Risk Stratify and Prognosticate Patients With Left Ventricular Hypertrophy (2006) (0)
The reply. (2015) (0)
DYNA-CT ) for 3 D Coronary Reconstruction and Myocardial Perfusion Assessment (2016) (0)
Abstract 4297: The Impact of Vascular Complications and Advanced Age on Outcomes Following Percutaneous Coronary Intervention (2009) (0)
PATENT FORAMEN OVALE CLOSURE VERSUS MEDICAL THERAPY TO PREVENT RECURRENT STROKE: A META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS (2018) (0)
Safety vs Efficacy of Lowering Blood Pressure. (2017) (0)
Age, Cardiovascular Risk, and Blood Pressure Target. (2018) (0)
The Changing Paradigm of Stress Echocardiography: Risk Stratification, Prognosis, and Future Directions (2010) (0)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. (2016) (0)
The relentless crumbling of the renin-angiotensin system (RAS)-blockade halo. (2016) (0)
EFFECT OF COOLING METHODS AND TARGET TEMPERATURE SELECTION ON OUTCOMES IN COMATOSE PATIENTS RESUSCITATED FROM CARDIAC ARREST: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2022) (0)
TCT-242 Outcomes with Coronary Artery Bypass Graft Surgery vs. Percutaneous Coronary Intervention for Patients with Diabetes Mellitus - Can Newer Generation Drug Eluting Stents Bridge the Gap? (2014) (0)
Abstract 12580: Intensive Lipid Lowering with Atorvastatin in Patients with Treatment Resistant Hypertension: An Analysis from the Treating to New Targets (TNT) Trial (2012) (0)
Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base? (2015) (0)
TCT-272 Impact of Dual Antiplatelet Therapy on Device Thrombosis after Left Atrial Appendage Occlusion (2017) (0)
IMPROVING ACCESS TO ADVANCED CARDIORESPIRATORY THERAPIES FOR UNDERSERVED PATIENTS AND MINORITIES WITH A MULTIDISCIPLINARY EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) PROGRAM IN A LARGE PUBLIC HOSPITAL NETWORK (2022) (0)
Physician preferences for revascularization in patients with ischemic cardiomyopathy: Defining equipoise from web-based surveys (2023) (0)
The risk of stent thrombosis of dual antithrombotic therapy for patients who require oral anticoagulant undergoing percutaneous coronary intervention: insights of a meta-analysis of randomized trials (2022) (0)
Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors? (2020) (0)
Abstract 10871: Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis (2015) (0)
The reply. (2014) (0)
The increasing proportion of acute myocardial infarction represented by the uninsured: a growing financial burden in the United States.(Report) (2014) (0)
Abstract 14766: Short-Term Dual Antiplatelet Therapy Following Bare Metal Stent Increases the Risk of Ischemic Events- A Meta-Analysis of Randomized Clinical Trials (2014) (0)
Reply: Hypertension Treatment in the Elderly: Individualized Target or Intensive Blood Pressure Lowering? (2017) (0)
EFFECT OF BIVALIRUDIN AND VASCULAR CLOSURE DEVICE ON THE BLEEDING OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTIONS (2011) (0)
Abstract 11151: Blood Pressure Targets in Patients with Coronary Artery Disease: Observations from Traditional and Bayesian Random Effects Meta-Analysis of Randomized Trials (2011) (0)
COVID-19 Myocarditis (2021) (0)
TEMPORAL TRENDS AND OPERATOR VARIATION IN ANTICOAGULANT USE DURING PERCUTANEOUS CORONARY INTERVENTION FOR PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN THE UNITED STATES (2016) (0)
Abstract 10755: Network Meta-Analysis of Randomized Controlled Trials of Eicosapentaenoic Acid for Cardiovascular Events Reduction (2021) (0)
Abstract 2100: Curative Ablation for Atrial Fibrillation: Is There a Late Attrition Rate? (2006) (0)
Cardiovascular death and cancer death--competing risk? (2012) (0)
TEMPORAL TRENDS IN CARE AND OUTCOMES OF PATIENTS WITH CARDIOGENIC SHOCK UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A REPORT FROM THE NCDR® (2015) (0)
READMISSIONS AFTER SURGICAL VERSUS MEDICAL MANAGEMENT OF DRUG USE-ASSOCIATED INFECTIVE ENDOCARDITIS COMPLICATED BY SEPTIC PULMONARY EMBOLI (2023) (0)
Abstract 19782: Is Multivessel Revascularization in Patients with ST-Segment Myocardial Infarction Associated with Increased Risk of Acute Complications? Insights from the NHLBI PCI Dynamic Registry (2010) (0)
ST-Segment Elevation Myocardial Infarction in the Morbidly Obese: Use of the "Offloading" Technique. (2021) (0)
TCT CONNECT-248 Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials (2020) (0)
Abstract 4695: Complete Revascularization versus Culprit-only Revascularization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Meta-Analysis (2009) (0)
Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials". (2021) (0)
Chronic Kidney Disease and CoronaryArtery Disease (0)
The reply. (2015) (0)
STRESS INDUCED DYSSYNCHRONY DURING LOW DOSE DOBUTAMINE INFUSION AS A PREDICTOR OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY. COMPARISON WITH REST DYSSYNCHRONY AND LEFT VENTRICULAR INOTROPIC CONTRACTILE RESERVE AS PREDICTORS OF RESPONSE (2012) (0)
BASELINE CHARACTERISTICS AND OUTCOMES BASED ON RENAL TRANSPLANT LISTING STATUS IN THE ISCHEMIA-CKD TRIAL (2021) (0)
Abstract 15647: Incidence and Outcomes of Hospitalizations Associated With Adverse Effects of Anticoagulation in Therapeutic Use (2014) (0)
Putting the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization Into Practice (2021) (0)
PERCUTANEOUS THROMBECTOMY USING ANGIOVAC SYSTEM AS A DIAGNOSTIC AND THERAPEUTIC TOOL IN MANAGING RIGHT ATRIAL MASS IN A HIGH-RISK PATIENT (2023) (0)
MANAGEMENT AND OUTCOMES OF PATIENTS WITH DIABETES MELLITUS (DM) AND STABLE ISCHEMIC HEART DISEASE (SIHD): POOLED DATA FROM THE ISCHEMIA AND ISCHEMIA-CKD TRIALS (2021) (0)
Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society of Cardiovascular Angiography and Interventions (2022) (0)
Abstract 3738: A Novel Critical Pathway for the Management of Hyperglycemia Facilitates a Rapid Intensive Glycemic Control in Critical Care Patients Without Causing any Hypoglycemic Episodes (2007) (0)
FP328LIPID LOWERING EFFICACY OF ATORVASTATIN IS RELATED TO IMPROVEMENT OF KIDNEY FUNCTION OVER TIME (2015) (0)
Abstract 11268: Fasting Low Density Lipoprotein Cholesterol (LDL-C) Levels Stratified by Fasting Time Do Not Have Significant Improvement in Prognostic Value versus Non-fasting LDL-C (2014) (0)
Abstract 10596: Telephone-Based Stress Management in Women with Myocardial Infarction: Findings from the Go Red for Women Strategically Focused Research Network (2021) (0)
Abstract 15428: Network Meta-analysis of Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement (2020) (0)
Overlap in Age at the Time of Elective Percutaneous Coronary Intervention and at Noncardiac Surgery. (2018) (0)
Abstract 11655: Long Term Cardiovascular Mortality After Radiotherapy for Breast Cancer: A Meta-Analysis (2014) (0)
Abstract 16233: Trends in Primary Percutaneous Coronary Intervention (PPCI) in Patients Presenting to Non-PCI Capable Hospitals With STEMI in New York State (2018) (0)
Low-Density Lipoprotein Cholesterol Levels and Statin Treatment—A Moving Target? (2017) (0)
Reply: Diabetic Hypertensives and Diastolic Dysfunction: Use of Calcium-Channel Blockers-A Clinical Concern. (2017) (0)
Abstract 16129: Optimal Treatment Strategies in Patients With Chronic Kidney Disease and Coronary Artery Disease: Insights From a Systemic Review and Meta-Analysis (2013) (0)
Abstract 13003: Efficacy of Cilostazol on Platelet Reactivity and Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention: Insights From a Meta-Analysis of Randomized Trials (2014) (0)
Abstract 10131: Baseline Characteristics, Quality of Care, and Short-Term outcomes of Young Patients Presenting with ST-Segment Elevation Myocardial Infarction: Insight from the Get With the Guidelines CAD Registry (2010) (0)
TANDEMHEART PERCUTANEOUS VENTRICULAR ASSIST DEVICE FOR THE TREATMENT OF REFRACTORY CARDIOGENIC SHOCK: A SINGLE CENTER EXPERIENCE (2010) (0)
Abstract 2987: Calcium Channel Antagonists Reduce the Risk of Stroke in Patients with Hypertension and Coronary Artery Disease: A Meta-Analysis (2006) (0)
TCT-844 Long term risk for major bleeding and ischemic events after PCI with implantation of everolimus-eluting stents: A Pooled-level Analysis of 8,020 Patients (2018) (0)
CARDIOVASCULAR HAZARDS POSED BY INSUFFICIENT TREATMENT OF DEPRESSION AMONG PATIENTS WITH KNOWN CARDIOVASCULAR DISEASES: INSIGHTS FROM A UNITED STATES BASED RETROSPECTIVE CLAIMS DATABASE ANALYSIS (2018) (0)
TCT-664 Twelve-Month Clinical Outcomes Comparing Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Coronary Stents in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Randomized Trial (2018) (0)
Abstract 16327: Clinical Profiles, Care Patterns, Outcomes and Sex Differences of Patients With STEMI in India: Insights From the North Indian ST-segment Elevation Myocardial Infarction (NORIN STEMI) Registry (2020) (0)
TCT-4 Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation (2022) (0)
EFFECTIVENESS OF BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN DURING PERCUTANEOUS CORONARY INTERVENTION AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN THE UNITED STATES (2016) (0)
Treating symptomatic carotid artery disease: deciding between carotid artery stenting and carotid endarterectomy - balancing the risks (2011) (0)
Meta-Analysis in the Mirror of its Quotations: Science, Scepticism, Scorn, and Sarcasm. (2019) (0)
Meta-analysis of PCI vs. CABG for left main disease revisited. (2020) (0)
Hospital Procedural Volume Predicts Short-term Outcomes for Patients Undergoing Procedures Requiring Large-bore Access. (2023) (0)
The ARB - MI Paradox - A Crumbling Hypothesis (2018) (0)
Reply (2018) (0)
When Results Also Allow the Opposite Conclusion…. (2015) (0)
Diagnosis and Treatment of Non-ST-Segment Elevation Myocardial Infarction (2008) (0)
Abstract 12971: Aspirin Use is Not Associated With Primary Prevention of All-Cause, Cardiovascular, or Oncologic Mortality (2014) (0)
Abstract 10908: Bare Metal Stents, Durable Polymer Drug Eluting Stents or Biodegradable Polymer Stents for Coronary Artery Disease: A Mixed Treatment Comparison Analysis of 254 361 Patient-Years of Follow-up From Randomized Trials (2013) (0)
Identification of gene expression profiles in myocardial infarction: a systematic review and meta-analysis (2018) (0)
LONG TERM OUTCOMES ASSOCIATED WITH VASCULAR CLOSURE DEVICE USE IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION VIA THE FEMORAL APPROACH: A PROPENSITY SCORE ADJUSTED, PROPENSITY SCORE MATCHED ANALYSIS (2010) (0)
Trends in the frequency of diagnosis of CKD among patients who present with a primary diagnosis of acute myocardial infarction (2016) (0)
Blood pressure control and mortality in US and foreign-born hypertensive African Americans served by NYC HHC (2016) (0)
Management of Cocaine-Induced Chest Pain (2008) (0)
Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. (2015) (0)
Faculty Opinions recommendation of Stenting versus endarterectomy for treatment of carotid-artery stenosis. (2010) (0)
RENIN ANGIOTENSIN SYSTEM INHIBITORS IN PATIENTS WITH CORONARY ARTERY DISEASE AND PRESERVED LEFT VENTRICULAR FUNCTION (2017) (0)
DAYS ALIVE OUT OF HOSPITAL WITH INITIAL INVASIVE VS CONSERVATIVE MANAGEMENT IN THE ISCHEMIA TRIAL (2021) (0)
Abstract 11971: Early Intravenous Beta Blockers Improve In-Hospital and Short-Term Mortality without Increasing the Risk of Cardiogenic Shock in Patients with Acute Coronary Syndrome-A Meta-Analysis (2011) (0)
TCT-719 Antithrombotic Strategies After Transcatheter Aortic Valve Implantation: Insights From a Network Meta-Analysis (2019) (0)
Of Assumptions, Potpourri and Sausages (2017) (0)
Abstract 2487: Relationship Between Heart Rate, Blood Pressure and In-hospital Mortality in Patients with Non-ST-segment Elevation Acute Coronary Syndromes: Results in 139,194 Patients (2006) (0)
Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Stroke Short title : PFO closure in cryptogenic stroke (2017) (0)
P2262Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials (2018) (0)
TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN END STAGE RENAL DISEASE: AN ANALYSIS OF THE NATIONWIDE INPATIENT SAMPLE DATABASE (2015) (0)
ASSOCIATION OF BMI ON WITH CLINICAL OUTCOMES IN PATIENTS WITH CORONARY DISEASE AND ADVANCED CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE ISCHEMIA-CKD TRIAL (2021) (0)
Baseline Characteristics of Patients With CAS Versus CEA Before and After Propensity Score Matching Parameter (2010) (0)
Beta blockers in hypertension - to use or not to use? (2008) (0)
The great taboo of non-infarct-related artery revascularization during primary percutaneous coronary intervention. (2013) (0)
Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial (2022) (0)
Teachable moment or missed opportunity? (2015) (0)
CHARACTERISTICS OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITOR MONOCLONAL ANTIBODY NEW USERS AND CHANGES IN LDL-C USING REAL-WORLD DATA: A U.S. PERSPECTIVE (2023) (0)
Correlation Between Head Computed Tomography Scans And The Neurological Exam In The Medical Intensive Care Unit (MICU) (2004) (0)
Elevated C-Reactive Protein Is Associated With Increased Risk of Mortality From Lung Cancer in the United States (2014) (0)
Abstract 5680: Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Meta-Analysis (2008) (0)
TCT-819 Safety and Efficacy of Mechanical Circulatory Support With Impella or Intra-Aortic Balloon Pump for High-Risk Percutaneous Coronary Intervention and/or Cardiogenic Shock: Insights From a Network Meta-Analysis (2019) (0)
Future Perspectives of Left Main Revascularization Trials. (2021) (0)
HETEROGENEITY IN TARGET ORGAN DAMAGE WITH INTENSIVE BLOOD PRESSURE CONTROL: AN UPDATED SYSTEMATIC REVIEW (2011) (0)
Polypill in Persons without Cardiovascular Disease. (2021) (0)
Factors associated with early catheterization in patients randomized to the conservative strategy in the ISCHEMIA Trial (2022) (0)
Abstract 2887: Peri-Operative Beta-Blockers in Patients Undergoing Non-cardiac Surgery: A Meta-Analysis of 12,306 Patients from Randomized Trials (2008) (0)
Meta-Analysis of Randomized Trials on the Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients 65Years of Age (0)
Updated meta-analysis on the efficacy of genotype-guided antiplatelet therapy versus standard therapy for patients undergoing PCI. (2020) (0)
Nephrology Consultative Approach and Risk Stratification Prior to Revascularization in Chronic Kidney Disease (2020) (0)
Abstract 10619: Oral Anticoagulant for Atrial Fibrillation in Patients on Dialysis: Insights From a Network Meta-analysis (2019) (0)
MYOCARDIAL INFARCTION RATES BY DEFINITION, TYPE, AND TREATMENT IN THE ISCHEMIA-CKD TRIAL (2021) (0)
Echo Assessment of Myocardial Viability (2009) (0)
The Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction with Single Vessel Disease : A Study of the Arbeitsgemeinschaft (2012) (0)
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function. (2022) (0)
ONE- VERSUS THREE-MONTH DAPT IN OLDER PATIENTS AT HIGH BLEEDING RISK UNDERGOING PCI: INSIGHTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM (2023) (0)
INTERNATIONAL COMPARISONS OF HEALTH STATUS OUTCOMES IN PATIENTS UNDERGOING INITIAL INVASIVE VERSUS CONSERVATIVE MANAGEMENT FOR CHRONIC CORONARY DISEASE: INSIGHTS FROM THE ISCHEMIA TRIAL (2023) (0)
Angiotensin Receptor Neprilysin Inhibitor Use and Blood Pressure Lowering in Patients With Heart Failure With Reduced Ejection Fraction Across the Spectrum of Kidney Function: An Analysis of the Veterans Administrative Health System. (2022) (0)
DIALYSIS INITIATION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE AND SEVERE CHRONIC KIDNEY DISEASE IN THE ISCHEMIA-CKD TRIAL (2021) (0)
Abstract 14884: Visit-to-Visit Variability in Body Weight and Risk of Cardiovascular Outcomes: Insights From the Treating to New Targets Trial (2015) (0)
BIFURCATION PCI TECHNIQUE IN THE ERA OF NEWER GENERATION DRUG ELUTING STENTS. INSIGHTS FROM A SYSTEMATIC REVIEW AND META ANALYSIS OF RANDOMIZED TRIALS (2021) (0)
Iconographies supplémentaires de l'article : Meta-Analysis of Randomized Clinical Trials Comparing Short-Term Versus Long-Term Dual Antiplatelet Therapy Following Drug-Eluting Stents (2014) (0)
EARLY INTRAVENOUS BETA-BLOCKERS BEFORE PCI, BUT NOT FIBRINOLYTICS IMPROVE IN-HOSPITAL MORTALITY IN SUBJECTS WITH STEMI (2013) (0)
2010 ASH Faculty (2010) (0)
Methodological Remarks Concerning the Recent Meta-analysis of Carotid Artery Stenting vs Carotid Endarterectomy—Reply (2011) (0)
Reply: Heart Rate Reduction and Cardiovascular Outcome in Hypertension. (2017) (0)
ACUTE HEMODYNAMIC CHANGES FOLLOWING PLACEMENT OF TANDEMHEART PERCUTANEOUS VENTRICULAR ASSIST DEVICE FOR REFRACTORY CARDIOGENIC SHOCK (2010) (0)
ody Weight Changes with-Blocker Use : esults from GEMINI ranz (2007) (0)
Practice patterns in extracorporeal life support in tertiary cardiac intensive care units in north america: a survey-based analysis from the critical care cardiology trials network (2023) (0)
VASCULAR CLOSURE DEVICE FAILURE AND VASCULAR COMPLICATIONS IN CONTEMPORARY PRACTICE (2011) (0)
Following Renal Outcomes With Staging in Percutaneous Coronary Intervention Trials. (2018) (0)
10-YEAR TRENDS IN INVASIVE VERSUS CONSERVATIVE MANAGEMENT OF UNSTABLE ANGINA/NON-ST-ELEVATION MYOCARDIAL INFARCTION (2013) (0)
Contents Vol. 126, 2013 (2013) (0)
Approach to Revascularization in the Potential Kidney Transplant Recipient (2020) (0)
Abstract 15708: Does Targeted Low Dose Heparin Negate the Efficacy and Safety of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention? Insights from a Propensity Score Matched Analysis of the EVENT Registry (2010) (0)
When Guideline Authors Ignore Their Own Guidelines. (2018) (0)
Is there an inter-manufacturer difference in generic clopidogrel response? (2022) (0)
VHRM-3339-Fixed combination of amlodipine and atorvastatin i (2009) (0)
GENDER DISPARITY IN THE NEW ACC/AHA RECOMMENDED REPERFUSION TIME IN ACUTE STEMI PATIENTS (2015) (0)
Abstract 14003: Outcomes With Invasive versus Conservative Management of Myocardial Infarction in Patients With Sepsis (2015) (0)
EFFICACY AND SAFETY OF THE NITINOL CLIP-BASED VASCULAR CLOSURE DEVICE (STARCLOSE) FOR FEMORAL ARTERIAL CANNULATION AT THE BIFURCATION: A PROPENSITY SCORE ADJUSTED ANALYSIS (2010) (0)
Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. (2022) (0)
2013 ACC/AHA GUIDELINE RECOMMENDATION ON BLOOD CHOLESTEROL REVISITED: PERCENT LDL-C REDUCTION OR ATTAINED LDL-C LEVEL OR BOTH FOR PROGNOSIS? (2015) (0)
Giant Cell Myocarditis: Not Always a Presentation of Cardiogenic Shock (2015) (0)
Who Needs Beta-Blockers? Analysis Raises Questions (2012) (0)
Diagnostic and Therapeutic Cardiovascular Procedures Right Heart Catheterization, Coronary Angiography, and Percutaneous Coronary Intervention (2011) (0)
Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery (2017) (0)
Abstract 15453: Are High Intensity Statins Beneficial in Patients With “High Intensity Like” LDL-C Reduction on Low Dose Statin: Insights From the TNT Trial (2019) (0)
Abstract 14816: Competing Risk of Myocardial Infarction vs Stroke in the Elderly Treated for Hypertension: A Meta-analysis of Randomized Trials (2014) (0)
Use of beta-blockers for uncomplicated hypertension in the elderly : a cause for concern. Commentary (2007) (0)
Response to "The effect of arteriovenous fistula (AVF) on hard endpoints should be observed prospectively in both CKD and non-CKD patients". (2019) (0)
TCT-470 Antithrombotic Therapy during Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Insights from Direct Comparison and Mixed Treatment Comparison Analysis of Randomized Trials (2014) (0)
The State of Coronary Thrombus Aspiration (2022) (0)
Dose-dependent effect of atorvastatin on long-term kidney function and associated cardiovascular outcomes (2015) (0)
Abstract 4729: Bare Metal vs. Drug-Eluting Stents for Calcified Lesion: Findings From the NHLBI PCI Dynamic Registry (2009) (0)
Treatment of Patients With Stable Ischemic Heart Disease--Reply. (2016) (0)
Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. (2021) (0)
Blood pressure reduction in elderly patients with hypertension decreases risk of adverse cardiovascular outcomes (2014) (0)
Risk Factors for Major Adverse Cardiac Events and Bleeding in Patients with Myeloproliferative Neoplasms Admitted for Myocardial Infarction (2022) (0)
TCT-450 Bare Metal Stent, Durable Polymer Drug Eluting Stent, or Biodegradable Polymer Drug Eluting Stent in Patients with Diabetes Mellitus - A Mixed Treatment Comparison Analysis of 63,940 Patient-Years of Follow-up from Randomized Trials. (2016) (0)
Abstract 4263: Angiotensin Converting Enzyme Inhibitors in Patients with Coronary Artery Disease and Preserved Left Ventricular Function: A Meta-Analysis of Randomized Controlled Trials. (2008) (0)
TCT-767 Effect of Renal Artery Denervation on Heart Rate: Insights from a Systematic Review and Meta-analysis. (2016) (0)
More SPRINT controversy (2018) (0)
Dual-Guide Triple-Kiss Technique for Left Main Trifurcation. (2021) (0)
Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI (2020) (0)
Inferior antihypertensive efficacy with low dose hydrochlorothiazide (2016) (0)
Abstract 14281: Door-To-Balloon Time Decreases With Pre-Hospital Wireless Electrocardiogram Transmission in Patients with ST-Segment Elevation Myocardial Infarction (2011) (0)
Faculty Opinions recommendation of Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (2009) (0)
Abstract 2151: Distensibility Characterization of Descending Thoracic Aortic Aneurysms Using Echocardiographic Strain and Doppler Tissue Imaging: Is Size the Only Important Character? (2006) (0)
DEBATING THE MERITS OF COMPLETE VERSUS CULPRIT-ONLY REVASCULARIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION WITH MULTI-VESSEL CORONARY DISEASE: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS (2016) (0)
ONE VERSUS THREE MONTH DAPT IN HIGH BLEEDING RISK PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: RESULTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM (2023) (0)
Abstract 2110: Beta-Blockers for Primary Prevention of Heart Failure in Patients with Hypertension: A Meta-Analysis of Randomized Controlled Trials (2007) (0)
Cognitive Decline, Blood Pressure Control and Variability: A Relentless Downward Spiral? (2016) (0)
Thanks to Reviewers2014 (2014) (0)
Rationale and design of the TUXEDO-2 India study: Ultra-Thin strUt Supraflex Cruz versus XiencE in a Diabetic pOpulation with multi-vessel disease-2. (2022) (0)
MAJOR ADVERSE CARDIAC EVENTS AND VENOUS THROMBOEMBOLISM RISK WITH JAK INHIBITORS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2022) (0)
TCT CONNECT-271 The MeRes-1 Extend Trial: 2-Year Clinical and 6-Month Imaging Outcomes of Thin-Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions (2020) (0)
Cardiovascular Death and Cancer Death—Competing Risk? Drs. Nabel and Braunwald 1 have ele- (2012) (0)
Steps for Successful Femoral Arterial Cannulation Conscious Sedation and Local Anesthesia (2011) (0)
VASCULAR CLOSURE DEVICE VERSUS MECHANICAL COMPRESSION FOR PREVENTION OF COMPLICATIONS: A PROPENSITY SCORE ADJUSTED ANALYSES OF 28487 PATIENTS UNDERGOING CORONARY DIAGNOSTIC AND INTERVENTIONAL PROCEDURES (2010) (0)
ANATOMY VERSUS ISCHEMIA IN THE ISCHEMIA-CKD TRIAL: DOES EITHER PREDICT OUTCOME? (2021) (0)
Abstract 10123: Evidence Against the J-shaped Curve in Treated Hypertensive Patients With Increased Cardiovascular Risk: The VALUE Trial (2015) (0)
TCT-342 Comparative Outcomes of Patients with Adult Congenital Heart Disease Admitted to US hospitals with STEMI (2017) (0)
DO STRESS ECHOCARDIOGRAPHY RESULTS ADD INCREMENTAL PROGNOSTIC VALUE IN PATIENTS WITH ANGIOGRAPHICALLY SIGNIFICANT CORONARY ARTERY DISEASE (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sripal Bengaluru?

Sripal Bengaluru is affiliated with the following schools:

Sripal Bengaluru's Academic­Influence.com Rankings

Sripal Bengaluru's Degrees

Similar Degrees You Can Earn

Why Is Sripal Bengaluru Influential?

Sripal Bengaluru's Published Works

Published Works

What Schools Are Affiliated With Sripal Bengaluru?

Sripal Bengaluru's AcademicInfluence.com Rankings